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Abstract
Objective The objective of this systematic review was to review the available evidence on the disparity between willingness 
to accept (WTA) and willingness to pay (WTP) for healthcare goods and services.
Methods A tiered approach consisting of (1) a systematic review, (2) an aggregate data meta-analysis, and (3) an individual partici-
pant data meta-analysis was used. MEDLINE, EMBASE, Scopus, Scisearch, and Econlit were searched for articles reporting both 
WTA and WTP for healthcare goods and services. Individual participant data were requested from the authors of the included studies.
Results Thirteen papers, reporting WTA and WTP from 19 experiments/subgroups, were included in the review. The WTA/
WTP ratios reported in these papers, varied from 0.60 to 4.01, with means of 1.73 (median 1.31) for 15 estimates of the 
mean and 1.58 (median 1.00) for nine estimates of the median. Individual data obtained from six papers, covering 71.2% 
of the subjects included in the review, yielded an unadjusted WTA/WTP ratio of 1.86 (95% confidence interval 1.52–2.28) 
and a WTA/WTP ratio adjusted for age, sex, and income of 1.70 (95% confidence interval 1.42–2.02). Income category and 
age had a statistically significant effect on the WTA/WTP ratio. The approach to handling zero WTA and WTP values has 
a considerable impact on the WTA/WTP ratio found.
Conclusions and Implications The results of this study imply that losses in healthcare goods and services are valued dif-
ferently from gains (ratio > 1), but that the degree of disparity found depends on the method used to obtain the WTA/WTP 
ratio, including the approach to zero responses. Irrespective of the method used, the ratios found in our meta-analysis are 
smaller than the ratios found in previous meta-analyses.
1 Introduction
The healthcare market is characterized by many imperfec-
tions, such as asymmetric information between patients and 
physicians, third-party payers, and uncertainty in demand 
and supply. Because of these market imperfections and 
government regulations, the price people pay for goods and 
services in the healthcare market does not necessarily reflect 
their value to them. Therefore, unlike the market for con-
sumer goods, it is difficult to use revealed preferences to 
determine the value of healthcare goods and services [1]. To 
circumvent this problem, health economists have regularly 
resorted to using stated preferences methods, such as con-
tingent valuation, to estimate the value of healthcare [2, 3].
An important application of stated preferences for health-
care is the cost-benefit analysis [4–6]. In this context, two 
measures have been used for valuing healthcare: willingness 
to pay (WTP) and willingness to accept (WTA). Willing-
ness to pay measures the amount of money an individual 
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is willing to pay for obtaining a certain healthcare good or 
service. Willingness to accept measures the amount of mon-
etary compensation an individual wants to receive for giving 
up a certain healthcare good or service. The relevant meas-
ure to use, thus, depends on the decision context, with WTP 
being used when people stand to gain something and WTA 
being used when people stand to lose something [4, 7, 8].
Previous studies have reported substantial differences 
between the WTP and WTA for the same good or service, 
both in hypothetical studies as well as in studies involving 
real transactions [9–11]. An aggregate data meta-analysis 
by Tunçel and Hammitt summarized the studies compar-
ing WTP and WTA across different economic sectors. They 
reported an overall WTA/WTP ratio of 3.28, indicating 
that people, on average, want to receive a 3.28 times larger 
amount to give up a good or service than they are willing 
to pay to obtain this good or service. The size of the WTA/
WTP ratio differed for the type of good valued, with studies 
on environmental goods reporting the largest WTA/WTP 
ratio of 6.23 on average [10]. A recent estimate of the WTA/
WTP ratio for healthcare goods and services is lacking, 
indicating a knowledge gap on the WTA-WTP disparity for 
the healthcare sector. The only review reporting a separate 
WTA/WTP ratio for healthcare [12] dates back to 2002 and 
included only two studies reporting ratios of 1.9 and 6.4 
[13, 14]. The more recent meta-analysis of Tunçel and Ham-
mitt [10] did not look at healthcare separately, but reported 
a mean ratio of 5.09 for health and safety goods together. 
Moreover, the search for this meta-analysis dates back to 
early 2012 and only covered one database (i.e., Econlit), 
indicating that the search could be updated and expanded 
to more databases to identify further relevant studies in the 
healthcare context.
In the literature, many different explanations for a dispar-
ity between WTA and WTP have been described. Accord-
ing to standard economic theory, WTA and WTP should be 
similar when the good valued is divisible and exchanged at 
zero transaction costs on an infinitely large market. If these 
conditions do not hold, WTA and WTP may be different. 
The size of this difference depends on income, the propor-
tion of income that is spent on the good, and the income 
elasticity [5, 6]. Furthermore, the inability to substitute 
money for a (public) good, either because of perfect com-
plementarity or because of asymptotic boundedness of the 
utility curve, may also be a reason for WTA to exceed WTP 
[15–17]. Moreover, according to several alternative eco-
nomic theories, such as prospect theory, (1) people value a 
change from a reference point, instead of the final state after 
a change, and (2) the value function for losses is steeper than 
the value function for gains. For these reasons, WTA values 
are expected to be larger than WTP values [18–20].
It is important to obtain more insight into the WTA/
WTP ratio for healthcare goods and services, as a dispar-
ity between WTA and WTP has important implications for 
healthcare decision making, for example for reimbursement 
decision making. If WTA is larger than WTP, a higher cost-
effectiveness threshold may be used for decisions on stop-
ping reimbursement of healthcare interventions as compared 
to decisions on starting reimbursement, in other words, the 
cost-effectiveness ratio should probably be significantly less 
favorable for disinvestment to be welfare improving. In line 
with this, insight into the WTA/WTP ratio for healthcare 
goods and services may be helpful to better understand reim-
bursement decision making as policy makers seem to find 
it more difficult to discontinue reimbursement than not to 
start reimbursement in the first place [21]. It may, therefore, 
also be important for researchers in the field of cost-benefit 
analysis of healthcare interventions and preference elicita-
tion to obtain more insight into the WTA/WTP ratio for 
healthcare goods and services, as insight into this issue pro-
vides guidance on choosing the appropriate measure of the 
value of healthcare interventions given the decision context 
at hand, i.e., investment vs disinvestment of healthcare goods 
and services. Furthermore, insight into the WTA/WTP ratio 
for healthcare goods and services may be helpful in under-
standing the general reluctance of patients to change treat-
ment despite potential advantages [22, 23], indicating that 
for a new treatment to be welfare improving, it should offer 
substantially higher benefits to the patient than the current 
treatment.
The aim of this study is to review the available evidence 
on the disparity between WTA and WTP for healthcare 
goods and services to obtain an aggregated estimate of the 
WTA/WTP ratio for healthcare goods and services. To this 
end, we used a comprehensive tiered approach consisting 
of (1) a systematic review, (2) an aggregate data meta-
analysis (AD-MA), and (3) an individual participant data 
meta-analysis (IPD-MA). First, the systematic review pro-
vides an overview of published studies that compared WTP 
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and WTA for healthcare goods and services. Second, the 
AD-MA combines the estimates as reported in these studies. 
Finally, the IPD-MA enables us to calculate one overall esti-
mate of the WTA-WTP disparity, to obtain more insight into 
the statistical and methodological uncertainty surrounding 
this estimate, and to correct the estimate for subject charac-
teristics. The IPD-MA approach has not been applied before 
to estimate the WTA/WTP ratio. Hence, this study adds a 
new level of information to the previous literature.
2  Methods
2.1  Systematic Review
The databases MEDLINE, EMBASE, Scopus, Scisearch, and 
Econlit were searched from inception to the search date (i.e., 
9 or 13 February, 2017) using WTP and WTA (and varia-
tions thereof) in the title, abstract, or as keywords. For the 
databases that do not solely focus on health (i.e., Scopus, Sci-
search, and Econlit), the search strategy was extended with 
health-related search terms. The full search strategies are 
displayed in Electronic supplementary material: Appendix A.
After deduplication, titles and abstracts were screened 
for eligibility by two reviewers using the eligibility criteria 
in Table 1. If eligibility was not clear from the title and 
abstract, the article was included in full-text screening to 
ensure that no eligible papers would be missed. Differences 
between reviewers were resolved by discussion. If a con-
sensus was not reached, a third reviewer was consulted. 
Full-text articles of all included abstracts were retrieved and 
screened for eligibility by one reviewer. If the reviewer was 
unsure about eligibility, the other reviewers were consulted.
For each included article, the estimate of the WTA/WTP 
ratio was extracted. If several estimates for different sub-
groups or experiments were provided, all these estimates were 
extracted. Next to the WTA/WTP ratio, the following (study) 
characteristics were extracted: first author, year, country, good/
service valued, number of study subjects (N), subject sample 
type, within- vs between-subject design, elicitation method, 
administration method, payment vehicle, and payment fre-
quency (see Electronic supplementary material: Appendix B).
2.2  Aggregate Data Meta‑Analysis
From the WTA/WTP estimates extracted in the systematic 
review, an overall WTA/WTP ratio was calculated. This 
was calculated by taking the mean and median from the 
WTA/WTP estimates as reported by the studies. If studies 
only reported mean/median WTA and WTP at the study 
level (i.e., not a ratio), the WTA/WTP ratio at the study 
level was calculated by dividing WTA by WTP. Next to the 
mean and median, a weighted average WTA/WTP ratio was 
calculated to take account of large differences in the number 
of subjects and number of estimates retrieved from stud-
ies [10, 11]. The estimates from the studies were weighted 
using this formula:
where N is the sample size of estimate k from study i and K 
is the number of estimates provided by study i. As the aggre-
gate WTA/WTP estimates were reported in different formats 
(i.e., mean, median, or regression model estimate), overall 
WTA/WTP ratios were calculated for each format separately.
2.3  Individual Participant Data Meta‑Analysis
Individual participant data (IPD) on WTP, WTA, age, sex, 
and income were requested by sending an e-mail to the cor-
responding authors of the papers included in the AD-MA. 
If it was not possible to contact the corresponding author, 
other authors were e-mailed. If necessary, the authors were 
reminded twice. The retrieved IPD were analyzed using three 
approaches increasing in complexity, which are described in 
the subsequent three paragraphs.
2.3.1  Descriptive Analyses
Received datasets were merged and harmonized into one 
dataset for analysis. To facilitate comparison and analysis, 
all WTP and WTA values were converted to the same base 
year and currency unit (i.e., 2017 Euros, Dutch price level) 
using the OECD purchasing power parities [24] and the 
consumer price index from Statistics Netherlands [25]. To 
test whether the studies included in the IPD-MA were dif-
ferent from the studies included in the AD-MA, an overall 
WTA/WTP ratio was calculated in a similar manner to the 
AD-MA. To this end, study-level WTA/WTP ratios were 
calculated by dividing mean/median WTA at the study level 
by mean/median WTP at the study level. From these study-
level WTA/WTP ratios, overall estimates were calculated by 
taking the mean, median, and weighted average from these 
estimates.
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Table 1  Eligibility criteria for the systematic review
Empirical studies (stated preferences)
Providing both willingness-to-pay and willingness-to-accept esti-
mates:
 for a comparable change
 in healthcare goods or services
 elicited in (1) the same subject or (2) two randomly allocated groups 
from the same sample
Published in English or Dutch
Full text available
 A. H. Rotteveel et al.
2.3.2  Mixed‑Model Analysis
Of the 4213 subjects included in the IPD dataset, 302 sub-
jects (7%) had a missing value on WTP, 218 subjects (5%) 
had a missing value on WTA, 1107 subjects (26%) had a 
missing value on both WTP and WTA, and 435 subjects 
(10%) had a missing value on income. As a complete case 
analysis, i.e., exclusion of respondents with missing values, 
may introduce bias, multiple imputation of WTA, WTP, 
and income was used. The imputation model used data on 
age, sex, income, country of study, and converted WTA and 
WTP. We used a fully conditional specification with predic-
tive mean matching to impute WTP and WTA when one was 
available and one was missing. The 1107 subjects with both 
WTP and WTA missing were excluded because they missed 
both parameters of interest for this study. Data were imputed 
ten times. All analyses were performed on each dataset sepa-
rately and, subsequently, the results were pooled according 
to Rubin’s rule [26]. As WTP, WTA, and the WTA/WTP 
ratio were not normally distributed, the data were then log-
transformed. As a result, respondents with WTA or WTP 
of zero were excluded from the analysis. As income was 
measured on different scales in different studies, income was 
dichotomized, based on median income (category) at the 
study level as a cut-off point. Subsequently, the log of WTA/
WTP ratio was estimated with a linear mixed model. A ran-
dom intercept was included to reflect any heterogeneity over 
studies in this outcome. The analysis was performed once 
without correction for covariates and once with correction 
for age, sex, and income. All analyses were performed with 
SAS 9.4 software (SAS Institute Inc., Cary, NC, USA).
2.3.3  Sensitivity Analyses: Zero Willingness to Pay and/
or Willingness to Accept
In the AD-MA and the descriptive analysis of IPD, data of 
subjects with zero WTP and/or WTA were included in the 
analysis. In the mixed-model analysis of IPD, subjects with 
zero responses were excluded from the analysis because log-
transformation of zero WTP and/or WTA is not possible. The 
best approach to dealing with zero responses in this context 
depends on the reasons behind zero responses (e.g., protest 
responses, not understanding the task, or an actual very low/
zero valuation [27–29]). In this meta-analysis, we were not 
able to determine the reason behind zero responses. There-
fore, to assess the potential impact of our main approach 
to zero responses on the WTA/WTP ratios, we conducted 
two sensitivity analyses. The first sensitivity analysis is 
the same as the descriptive analysis of IPD as described in 
Sect. 2.3.1; however, excluding subjects reporting zero WTP 
and/or WTA. The second sensitivity analysis is the same as 
the mixed-model analysis, described in Sect. 2.3.2; how-
ever, including subjects reporting zero WTP and/or WTA, 
by replacing their zero value by one-half, one-third, or one-
quarter of the smallest value reported in the study concerned. 
This approach especially makes sense if subjects reported 
zero values because their WTP or WTA was too small to be 
picked up by the elicitation procedure used.
3  Results
3.1  Systematic Review
Databases were searched on the 9 February, 2017 (MED-
LINE and EMBASE) and 13 Feburary, 2017 (Scopus, Sci-
search, and Econlit). In total, 396 records were identified 
of which, after removal of 231 duplicates, 165 remained 
for title and abstract screening. Of the 31 articles that were 
included in full-text screening, 13 were included in the 
review (see Electronic supplementary material: Appendix 
C). Figure 1 displays the PRISMA (Preferred Reporting 
Items for Systematic Reviews and Meta-Analyses) flow 
diagram.
Table 2 displays the descriptive characteristics and the 
extracted WTA/WTP ratios of the studies included in the 
systematic review. The 13 included studies provided esti-
mates for 19 different experiments or subgroups.
3.2  Aggregate Data Meta‑Analysis
The WTA/WTP ratios calculated from the extracted WTA/
WTP estimates are displayed in Table 3. A mean WTA/WTP 
ratio of 1.73 for 15 mean estimates and a mean ratio of 1.58 
for nine median estimates were found. The weighted average 
was 1.87 for mean estimates and 1.55 for median estimates. 
The small differences between the crude and weighted aver-
ages indicate that the estimates provided by studies with 
more subjects and/or more experiments/subgroups were not 
very different from other studies. One study [35] did not 
report mean or median, but reported a regression model esti-
mate of the WTA/WTP ratio instead. This estimate of 3.20 
was relatively high compared with the mean WTA/WTP 
ratio for mean and median estimates.
3.3  Individual Participant Data Meta‑Analysis
From the 13 studies included in the AD-MA, six datasets 
were obtained for inclusion in the IPD-MA (see Fig. 1). For 
the remaining seven studies, the data could not be included 
because of non-response (n = 3) or because the authors were 
not able to send the data (n = 4). The six datasets received 
covered 71.2% of the subjects who were included in the 
AD-MA, implying that the samples we could not include 
were relatively small compared with the samples we were 
able to obtain.
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3.3.1  Descriptive Analyses
Descriptive information of the six datasets received is dis-
played in Table 4. Of the 4213 subjects included in the 
six datasets, 1107 subjects were excluded from the analy-
sis because they had both WTP and WTA missing. Of 
the remaining 3106 subjects, 299 subjects (10%) reported 
a WTP of zero, 69 subjects (2%) a WTA of zero, and 77 
subjects (2%) both a WTP and a WTA of zero. This left 2661 
subjects for the mixed-model analyses.
Table 5 displays the WTP and WTA per study after 
conversion to 2017 Euros (for raw data, see Electronic 
supplementary material: Appendix D) and the results of 
the descriptive analysis. The study-level estimates of the 
WTA/WTP ratios were similar to the estimates found in 
the AD-MA. This indicates that the subsample of studies 
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included in the IPD-MA was not that different from all stud-
ies included in the AD-MA. Electronic supplementary mate-
rial: Appendix E shows the WTA/WTP ratio for different 
levels of age, sex, and income. As expected, the ratio was 
higher in people with a lower income compared with people 
with a higher income. Furthermore, the two intermediate age 
groups reported lower WTA/WTP ratios compared with the 
youngest and the oldest age category.
3.3.2  Mixed‑Model Analysis
Table 6 displays the results of the mixed-model analysis. 
The unadjusted WTA/WTP ratio was 1.86 (95% confidence 
interval 1.52–2.28). Age and income category both had a 
statistically significant effect on the WTA/WTP ratio found. 
The Table in Electronic supplementary material: Appendix 
F displays the ln(WTA/WTP ratio) and the WTA/WTP ratio 
for different groups of subjects. The figures in Electronic 
supplementary material: Appendix F display the trend of the 
WTA/WTP ratio for different types of subjects, based on the 
ln(WTA/WTP) slope estimates. The largest difference in the 
WTA/WTP ratio of 0.45 was found between high-income 
30-year-old individuals and low-income 65-year-old indi-
viduals. Furthermore, the difference between the low- and 
high-income groups increased with increasing WTA and 
WTP values.
3.3.3  Sensitivity Analysis: Zero Willingness‑to‑Pay and/
or Willingness‑to‑Accept Values
The merged dataset contained 445 subjects (14%) with a 
WTA, WTP, or both WTA and WTP of zero (Table 4). 
Table 7 displays the results of the first sensitivity analysis. 
These results have been obtained in the same manner as the 
results in Table 5, only with exclusion of the 445 subjects 
reporting zero WTA and/or WTP. This analysis shows that 
the exclusion of zero WTA and/or WTP generally resulted 
in lower WTA/WTP ratios, with this effect being most 
pronounced for the mean and median WTA/WTP ratios 
obtained from average WTA and WTP at the study level 
compared with those obtained from median WTA and WTP 
at the study level. Furthermore, unsurprisingly, the impact 
was largest in the studies with more subjects reporting zero 
WTP.
Table 8 displays the results of the second sensitivity 
analysis, the mixed-model analysis with replacement of zero 
values with either one-half, one-third, or one-quarter of the 
smallest value reported in the study from which the subjects 
reporting zero WTA and/or WTP originated from. These 
results have been obtained in a similar manner to the results 
in Table 6. The estimated WTA/WTP ratios were much 
larger when zeroes were replaced by a small value compared 
with when zeroes were excluded from the analysis. This may 
partly be caused by the large smearing factors in the sensitiv-
ity analyses (3.7–5.7 in the sensitivity analyses vs 1.3 in the 
original analysis) caused by the artificial “spike” at the lower 
end of the distribution because of the imputation of zeroes 
with small values. The estimated WTA/WTP ratios were 
larger when the replacement values were smaller.
4  Discussion
The aim of this study was to review the available evidence 
on the disparity between WTA and WTP for healthcare 
goods and services using a comprehensive tiered approach 
consisting of (1) a systematic review, (2) an AD-MA, and (3) 
an individual participant data meta-analysis. In the AD-MA, 
we found an average WTA/WTP ratio of 1.73 (median 1.31) 
for mean estimates and of 1.58 (median 1.00) for median 
estimates. In the IPD-MA, we found an uncorrected WTA/
WTP ratio of 1.86 (95% confidence interval 1.52–2.28) and 
a WTA/WTP ratio adjusted for age, sex, and income of 1.70 
(95% confidence interval 1.42–2.02). The approach to deal 
with zero WTP and/or WTA values considerably impacted 
the WTA/WTP ratio found.
This study found a significant effect of income category 
and age on the WTA/WTP ratio. No effect of sex was found. 
As previous meta-analyses on WTA and WTP have not 
tested the effect of age, sex, and income on the WTA/WTP 
ratio, it is not possible to compare these findings with other 
studies. However, these findings seem to correspond with 
the well-known income effect, which says that because WTP 
is constrained by income while WTA is not, there may be 
a substantial disparity between WTA and WTP when (1) 
the change concerned is large, (2) the value of the good 
concerned is high, or (3) the income elasticity for the good 
concerned is high and increasing with income [5, 15]. The 
reason for this is that when the value of the good increases, 
the WTP will increase until the income constraint is reached, 
while WTA would become infinite. As people with lower 
incomes have a lower income constraint than people with 
Table 3  Willingness-to-accept/willingness-to-pay estimates obtained 
from aggregate data
NA not applicable as it concerns one estimate
Mean estimates Median 
estimates
Regression 
model esti-
mates
Mean 1.73 1.58 3.20
Weighted average 1.87 1.55 NA
Median 1.31 1.00 3.20
Number of estimates 
(from number of 
studies)
15 (10) 9 (7) 1 (1)
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higher incomes, the WTA-WTP disparity should be larger 
for people with lower incomes than for people with higher 
incomes, as was indeed was found in this study.
To obtain an impression of the impact of our approach 
to zero WTP and/or WTA responses in our main analyses, 
we have conducted two sensitivity analyses. The results 
of these sensitivity analyses indicate that the approach to 
dealing with subjects reporting zero WTP and/or WTA 
may considerably affect the WTA/WTP ratio. To our 
knowledge, the issue on how to deal with zero WTP and 
WTA has not received much attention in the scientific liter-
ature so far. To determine the best approach to dealing with 
zero responses, it is important to know the rationale behind 
reporting zeroes in stated preference studies. Qualitative 
inquiry during or directly after the administration of the 
WTP and WTA task may provide more insight into the 
reasons behind zero responses and subsequently provide 
guidance on the most valid approach of dealing with zero 
responses (which may be another approach than was used 
in this meta-analysis). Some studies already included 
follow-up questions when eliciting WTP and found that 
zero responses may be protest responses as well as real 
zeroes [27–29]. However, more research on the rationale 
behind zero responses and the best approach to deal with 
these zero responses in the analysis is warranted. Further-
more, to prevent analysis and interpretation problems with 
regard to zero WTP and/or WTA such as encountered in 
our review, we recommend future research to decrease 
Table 5  Willingness-to-pay (WTP), willingness-to-accept (WTA) and WTA/WTP estimates based on individual participant data (converted to 
2017 Euros)
NA not applicable, SD standard deviation
a Calculated from study-level WTA and WTP: mean WTA/WTP = mean WTA/mean WTP; median WTA/WTP = median WTA/median WTP
b Subjects with either WTA or WTP missing were still included in this analysis. Therefore, this N is higher than the N for WTP and WTA sepa-
rately
c Median WTP is zero. Therefore, the WTA/WTP ratio based on medians could not be calculated for the study of Borisova et al
d As informal caregivers reported WTP and WTA for 1 hour extra per week and patients reported WTP and WTA for 1 hour extra per day, the 
good valued is not comparable between these groups. Therefore, the subgroups are reported separately
First author (year) WTP WTA WTA/WTPa
N Mean (SD) Median (quartiles) N Mean (SD) Median (quartiles) Nb Mean Median
van den Berg (2005) [31] 241 10.30 (5.85) 8.85 (5.90|11.80) 246 11.83 (7.19) 10.47 (8.85|14.75) 270 1.15 1.18
Borisova (2003) [32] 303 3.11 (6.23) 0.00 (0.00|3.78) 303 9.74 (13.60) 6.30 (1.10|12.60) 303 3.13 NAc
Chiwaula (2016) [33] 92 18.82 (23.80) 10.25 (6.15|20.50) 92 37.13 (36.60) 24.60 (14.35|48.69) 92 1.97 2.40
Martin-Fernandez (2010) [37] 451 26.09 (23.24) 23.94 (10.64|37.24) 450 47.94 (30.03) 47.22 (23.94|60.52) 451 1.84 1.97
Martin-Fernandez (2013) [38] 653 18.40 (19.35) 12.80 (6.40|23.60) 648 26.75 (21.92) 25.60 (12.80|38.40) 653 1.45 2.00
de Meijer (2010) [39]d
Suppliers 753 11.49 (7.30) 11.44 (8.58|14.29) 849 13.20 (8.51) 11.44 (8.58|14.29) 992 1.15 1.00
Patients 311 8.70 (6.73) 8.58 (5.72|11.44) 300 11.33 (8.17) 10.29 (5.72|14.29) 345 1.30 2.30
Mean 3106 1.71 1.63
Weighted average 3106 1.70 1.63
Median 3106 1.45 1.59
Table 6  Willingness-to-accept/willingness-to-pay (WTA/WTP) ratios obtained from the mixed-model analysis of individual participant data
CI confidence interval, SE standard error
a The estimate and CI were retransformed to the original scale with a smearing factor [42]
b This estimate is for men aged 50 years in the highest income category (= reference levels of the variables)
Model Variable Original results After  retransformationa
Estimate SE 95% CI P value I2 (%) Estimate 95% CI
Unadjusted ln (WTA/WTP) 0.369 0.104 0.165 0.573 < 0.01 88 1.862 1.519 2.284
Adjusted ln (WTA/WTP)b 0.281 0.090 0.106 0.457 < 0.01 91 1.696 1.422 2.022
Age 0.003 0.001 0.001 0.006 0.01
Sex (female) 0.016 0.033 − 0.049 0.081 0.63
Income category (low) 0.131 0.054 0.026 0.237 0.01
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the number of zero responses by using other contingent 
valuation methods than open-ended questions, as previ-
ous reviews have shown that open-ended question formats 
are more prone to zero responses than other contingent 
valuation methods [2, 43]. Moreover, when using a closed-
ended question format, researchers are recommended not 
to include the value zero in the option list, but, instead, to 
only provide the option ‘the good is not worth anything to 
me’. This will force subjects to think twice before report-
ing a zero, which will decrease the number of non-true 
zero responses. For the remaining zero responses, to deter-
mine how to best handle these individual zero responses 
in the analysis (e.g., exclusion or imputation), researchers 
are recommended to include a probing question that pops 
up if respondents report zero WTP and/or WTA. Answer 
options should at least cover the following possible reasons 
underlying zero responses: not understanding the ques-
tion, protest response, value of the good is smaller than 
the answer option provided, and true zero (‘the good is not 
worth anything to me’). Including such a probing question, 
will open the ‘black box’ of zero responses, facilitating the 
decision on how to deal with individual zero responses in 
the analysis, and will force subjects to think about their 
zero response, which may, in some cases, result in subjects 
changing their zero into their true value.
4.1  Comparison with Previous Studies
The WTA/WTP ratios found in our meta-analysis are con-
siderably lower than those found in previous meta-analyses/
reviews. A possible explanation of this may be that one of 
the studies included in the review by O’Brien et al. was 
not included in our meta-analysis as it was not identified 
in our search because the title and abstract did not contain 
WTA or variations thereof. This study reported a very high 
WTA/WTP ratio of 6.4 for a non-fatal injury, which may 
be explained by the fact that the change valued in the WTA 
scenario (i.e., no injury vs full injury) was larger than the 
change valued in the WTP scenario (i.e., small injury vs full 
injury) [14]. Hence, it may not be surprising that this ratio is 
much larger than the ratios found in our meta-analysis. The 
estimate for health and safety goods in the meta-analysis by 
Tunçel and Hammitt was obtained from 11 studies of which 
seven were not included in our meta-analysis. These seven 
studies reported generally larger WTA/WTP ratios than the 
studies included in our meta-analysis and predominantly val-
ued traffic safety, job safety, and product safety, i.e., safety 
goods [10]. This indicates that the WTA/WTP disparity may 
be larger in safety studies than in health studies, which may 
explain why our meta-analysis found a smaller disparity 
and stresses the need for a separate WTA/WTP estimate for 
Table 8  Willingness-to-accept/willingness-to-pay (WTA/WTP) ratios obtained from the mixed-model analysis with replacement of zero values
CI confidence interval, SE standard error
a The estimate and CI were retransformed to the original scale with a smearing factor [42]
b This estimate is for men aged 50 years in the highest income category (= reference levels of the variables)
Model Variable Original results After  retransformationa
Estimate SE 95% CI P value I2 (%) Estimate 95% CI
Zero = 1/2 of the smallest value in the dataset
 Unadjusted ln (WTA/WTP) 0.711 0.223 0.273 1.149 < 0.01 88 7.538 4.867 11.675
 Adjusted ln (WTA/WTP)b 0.561 0.241 0.090 1.033 0.02 86 6.475 4.040 10.377
Age < 0.001 0.003 − 0.006 0.006 0.96
Sex (female) 0.025 0.046 − 0.065 0.115 0.59
Income category (low) 0.269 0.071 0.129 0.408 < 0.01
Zero = 1/3 of the smallest value in the dataset
 Unadjusted ln (WTA/WTP) 0.750 0.241 0.278 1.222 < 0.01 88 10.088 6.292 16.175
 Adjusted ln (WTA/WTP)b 0.590 0.259 0.082 1.096 0.02 86 8.550 5.149 14.200
Age < − 0.001 0.004 − 0.007 0.006 0.95
Sex (female) 0.026 0.049 − 0.070 0.122 0.59
Income category (low) 0.292 0.075 0.144 0.440 < 0.01
Zero = 1/4 of the smallest value in the dataset
 Unadjusted ln (WTA/WTP) 0.778 0.254 0.281 1.275 < 0.01 88 10.371 6.310 17.048
 Adjusted ln (WTA/WTP)b 0.608 0.272 0.0756 1.141 0.03 86 10.557 6.196 17.987
Age < − 0.001 0.004 − 0.008 0.007 0.95
Sex (female) 0.027 0.051 − 0.073 0.127 0.59
Income category (low) 0.308 0.079 0.154 0.462 < 0.01
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healthcare goods and services, as has been obtained in our 
meta-analysis.
Another possible explanation for the relatively small 
WTA-WTP disparity found in our review may be that 
the studies included in our review valued relatively small 
changes in healthcare goods and services, such as 1 hour 
of informal care or one general practitioner consultation. 
According to standard economic theory, owing to declin-
ing marginal utility, the WTA/WTP ratio is an increasing 
function of the size of the change valued [44]. As a conse-
quence, the WTA/WTP ratio is anticipated to be larger when 
the changes in healthcare goods and services to be valued 
are truly substantive, such as a year of informal care or an 
orphan drug. To assess the degree to which the WTA/WTP 
ratio for healthcare goods and services is an increasing func-
tion of the size of the change valued, we recommend future 
research to estimate the WTA/WTP ratio for differently sized 
changes in the healthcare good or service concerned.
Furthermore, another possible explanation for the rela-
tively low WTA/WTP ratio found in our review may be that 
subjects were quite familiar with the goods being valued. 
Three studies asked informal caregivers and/or informal care 
recipients to value informal care. Furthermore, two studies 
valued primary care (general practitioner or nurse), which 
is a type of care many people are familiar with. If people 
are more familiar with the goods they value, they are more 
certain about their preferences and therefore report WTA 
and WTP values that are closer together [45]. Furthermore, 
many studies in this meta-analysis elicited WTA and WTP in 
the same questionnaire. Therefore, subjects could have used 
one of the measures as a reference for the other.
4.2  Implications of our Findings
The results of this study imply that losses in healthcare goods 
or services are valued somewhat differently from similarly 
sized gains in healthcare goods and services. This may have 
implications for cost-benefit analyses of healthcare interven-
tions. In cost-benefit analyses, the welfare effect of health-
care interventions is transformed into monetary units using 
the WTP for gains in healthcare and the WTA for losses in 
healthcare. However, as shown, losses in healthcare have a 
different weight than gains in healthcare. There has been con-
siderable debate across different economic sectors on whether 
WTA or WTP should be used in the context of losses. Some 
authors, such as those from the National Oceanic and Atmos-
pheric Administration Panel on Contingent Valuation, argue 
that WTP should always be used because WTA is biased 
and WTP constitutes a more conservative estimate of welfare 
change [46]. Others argue that WTA is valid and, hence, that 
the most accurate measure of welfare change depends on the 
direction of the change from the reference point [47, 48]. 
This debate is still ongoing and our study does not provide 
any conclusive answers to resolve this issue.
Furthermore, our findings may have implications for 
reimbursement decision making based on cost-effective-
ness/cost-utility analyses. Although the effects of healthcare 
goods and services are expressed in health units in cost-
effectiveness analyses and in quality-adjusted life-years in 
cost-utility analyses, WTA and WTP still need to be used to 
make reimbursement decisions based on these analyses. In 
many countries, implicit or explicit thresholds for the WTP 
for additional health outcomes have been used in reimburse-
ment decision making. For instance, the National Institute 
for Health and Care Excellence in England and Wales uses 
a threshold of £20,000–£30,000 per quality-adjusted life-
year gained [49, 50], and the National Health Care Institute 
in the Netherlands uses a threshold of €20,000–€80,000 
per quality-adjusted life-year gained, depending on disease 
severity [51]. However, a threshold for the WTA for a loss 
in health does not exist. Therefore, the WTP threshold has 
often been used for such decisions [52]. However, as our 
study shows, the WTA for healthcare goods and services is 
somewhat higher than WTP. Therefore, to align policy with 
societal preferences, one might argue to use a somewhat 
higher threshold in the domain of losses compared to the 
domain of gains.
To this end, Severens et al. suggested to use a modified 
cost-effectiveness acceptability curve approach to provide 
insight into the impact of the WTA-WTP disparity on the 
probability of an intervention being cost effective. This 
information could then be incorporated in reimbursement 
decision making, facilitating a societal debate on this issue 
[53]. However, others have suggested that the same thresh-
old should be used for decisions in the context of gains and 
losses, as using different thresholds may introduce substan-
tial inefficiencies in the allocation of the healthcare budget 
[54–56]. Hence, whether the WTA-WTP disparity should 
be incorporated in healthcare policy making is a political 
trade-off between aligning policy with societal preferences 
on the one hand, and stimulating efficiency in the allocation 
of healthcare budgets on the other hand.
Furthermore, the results of this study can also be used to 
better understand problems with disinvestment, which is the 
full/partial withdrawal of the reimbursement of healthcare 
interventions [57]. Decisions on disinvestment have often 
been perceived to be much more difficult than decisions 
on (not) starting reimbursement of healthcare [58, 59], a 
phenomenon that has also been observed in the context of 
conditional reimbursement [21]. In this study, we found a 
small disparity between WTA and WTP, implying that, in 
the healthcare context, people attach more value to losses 
than to gains. This may also partly explain the perceived 
difficulty of disinvestment compared to investment as the 
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former is in the domain of losses and the latter is in the 
domain of gains.
4.3  Strengths and Limitations
In this study, we used a systematic approach to estimate the 
WTA/WTP ratio for healthcare goods and services. The 
eligibility criteria were strictly applied to derive WTA and 
WTP estimates that were based on a similar change and elic-
ited in the same manner. In this approach, we ensured that 
the WTA/WTP ratios derived were not biased by incompa-
rable WTA and WTP scenarios. Furthermore, by combining 
data from different studies in our meta-analysis, we were 
able to obtain a higher level of evidence and more insight 
into the uncertainty surrounding the disparity between WTA 
and WTP than previous studies did.
Our study, however, also has some limitations. First, 
the studies included in our meta-analysis were quite het-
erogeneous as different (changes in) healthcare goods and 
services were valued by different subject groups using dif-
ferent elicitation and administration methods. Furthermore, 
studies were conducted in different settings. Because of 
the small number of studies available, we were not able to 
test the effect of these different settings and methods on the 
WTA/WTP ratio for healthcare goods and services. There-
fore, more studies on the WTA/WTP ratio for healthcare 
goods and services are needed to obtain more insight into 
this issue.
Second, as we have not tested the quality of the included 
studies, we were not able to weight the study estimates based 
on their quality. However, we are not aware of any quality 
assessment instrument applicable to WTA/WTP studies, 
hampering the incorporation of study quality in the analyses.
Third, although we were able to include the largest stud-
ies from our review in the IPD-MA, the number of studies 
included in this meta-analysis is still quite small. Further-
more, most studies included in the IPD-MA valued informal 
care or primary care services. Therefore, our results can-
not be generalized to all healthcare goods and services in 
general. More research is needed to obtain insight into the 
WTA/WTP ratio for a broader range of healthcare goods 
and services.
Fourth, in the mixed model, we calculated the WTA/
WTP ratio using the mean of ratios approach. We are aware 
that using the ratio of means approach instead could have 
resulted in a different estimate of the WTA/WTP ratio [60, 
61]. However, because of differences in the goods and ser-
vices valued in the included studies, we were not able to use 
the ratio of means approach and to determine the effect of 
using one approach over the other on the WTA/WTP ratio.
Fifth, in our analysis, we assumed the association between 
age and ln(WTA/WTP) to be linear. However, some studies 
showed small deviations from this assumption. Nonetheless, 
as correcting for non-linearity would not result in signifi-
cantly improved model fits, we decided not to correct for 
this, applying the credo: “as simple as possible, as complex 
as necessary”.
Finally, we have used the median as a cut-off point to 
transform the income data into two categories. Although 
there was no better option to combine the income data, this 
approach may have hampered the interpretation of the effect 
of income. The reason for this is that the study population 
may not reflect the general population in terms of income. 
For instance, in the study on the valuation of methadone 
maintenance, it is imaginable that the respondents had a 
relatively low income. The implication of this would be that 
our income categories based on a median income actually 
represent a very low vs a quite low income.
5  Conclusions and Recommendations
This study found aggregated WTA/WTP ratios between 
1.58 and 1.86 for healthcare goods and services, indicating 
that losses are weighted somewhat differently from gains. 
The ratio found depends on the method used to calculate 
the WTA/WTP ratio and the approach on how to deal with 
subjects reporting zero WTP and/or WTA. Irrespective of 
the method used, the ratios found in our meta-analysis were 
smaller than the ratios found in previous meta-analyses. For 
this reason, the WTA-WTP disparity in the healthcare sec-
tor may be less of a problem than what was thought based 
on previous studies. However, we cannot exclude the pos-
sibility that the relatively small disparity found is related 
to the fact that the studies in our review valued relatively 
small gains and losses in healthcare goods and services, with 
which subjects were quite familiar. Future empirical work 
may explicitly test the effect of size of the change valued on 
the WTA/WTP ratio through a within-person assessment of 
differently sized changes in healthcare goods and services. 
Furthermore, we recommend future research to pay attention 
to the reasons behind zero WTA and WTP responses and the 
best methodological means of dealing with these responses 
in the analysis.
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